"Results so far published have shown that CAM can contribute to improving the quality of life of cancer patients and their general well-being (Adams and Jewell, 2007) and CAM modalities play a role in supportive care and cancer (Leis and Millard, 2007). For example, today, this kind of therapy is used in many countries of the world, including development countries (Wolf et al., 2006; Simon et al., 2007; Tovey et al., 2006; Montazeri et al., 2007). Not only adult but paediatric cancer patients have used CAM too (Gomez- Martinez et al., 2007; Lim et al., 2006; Karadeniz et al., 2007; Gözüm et al., 2007). "
[Show abstract][Hide abstract] ABSTRACT: Many cultures have used plants to treat medical affections and a percentage of modern medicines are obtained from plants. Today, several herbals have been screened for anticancer activity and many patients with cancer take plant extracts in addition to chemotherapy. This review offers an overview of the knowledge about the use of herbals and derivatives as a viable anticancer alternative therapy and their interactions (particularly, modulation of P-450 system and P-glycoprotein) with conventional anti-cancer drugs. It is suggested that health care professionals and patients should be aware of the potential for adverse interactions of this products with the anti-cancer drugs.
[Show abstract][Hide abstract] ABSTRACT: Summary form only given. The US EUV Lithography Program has focused on demonstrating all critical technologies essential for early access to production tools. In addition to individual components, techniques, and metrologies, a major effort was completion of the alpha-like tool, the Engineering Test Stand (ETS). Progress to date is based on a close collaboration between technical staff at the Virtual National Laboratory, consisting of Sandia, Lawrence Livermore, and Lawrence Berkeley National Laboratories, member companies of the EUV Limited Liability Company (Intel, Motorola, AMD, Infineon, Micron and IBM), and a wide array of vendors and suppliers. In this paper, we review progress on aspheric optical substrates, multilayer coating reflectivity and uniformity, scattering and flare. We briefly describe requisite visible light and at-wavelength metrologies. Progress on EUV masks (reticles) is reported, including specifications, patterning with candidate materials, inspection, and standards. Progress on sources of EUV radiation is reported, and related to recently published wafer throughput models. Results of wafer exposures are presented for two sets of optics. Looking to the future, emphasis is placed on collaborative efforts and partnering directed towards early access to beta and production tools
Microprocesses and Nanotechnology Conference, 2001 International; 02/2001
[Show abstract][Hide abstract] ABSTRACT: Many cancer patients within developed nations cite the media as informing their decisions to use complementary and alternative medicine (CAM). The present study describes (1) Australian newspaper coverage of CAM use for cancer between 1998 and 2007; (2) trends in reporting frequency and characteristics; and (3) how the Australian press framed stories on CAM use for cancer.
This study is a content analysis featuring quantitative and qualitative techniques, the latter guided by 'media framing', of targeted newspaper articles.
One hundred nineteen articles focused on CAM use for the treatment of cancer were identified. Quantitative analysis found that biologically based CAMs were most frequently described and breast cancer most mentioned. Two thirds of all articles described CAM use in the context of a cure, with approximately half of these opposing this reason for use. Potential benefits of CAM were discussed more frequently than potential risks, and information on costs and how to access CAM were uncommon. Recommendations included advice to use complementary, not alternative therapies, yet advice to discuss CAM with a medical doctor was rare. Qualitative analysis found six CAM cancer-related frames, four in support of CAM use for cancer treatment. The dominant frame constructed CAM as legitimate tools to assist biomedicine (even to cure), with others depicting CAM as normal and necessary or as addressing limitations of biomedicine. Negative frames depicted CAM as questionable and risky practices and the industry/practitioners as possessing malevolent intent.
These findings have implications for biomedical practitioners attempting to determine, respect and assist patient choices about their treatment.
Supportive Care in Cancer 11/2009; 19(1):67-80. DOI:10.1007/s00520-009-0790-4 · 2.36 Impact Factor
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed. The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual current impact factor. Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence agreement may be applicable.